The U.S. revenue cycle management market size was USD 52.36 billion in 2023, estimated at USD 58.53 billion in 2024 and is anticipated to reach around USD 175.23 billion by 2034, expanding at a CAGR of 12% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Revenue Cycle Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Revenue Cycle Management Market, by Function, 2024-2034
8.1.1. Product Development
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Member Engagement
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Network Management
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Care Management
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Claims Management
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Risk and Compliances
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. US Revenue Cycle Management Market, by Product, 2024-2034
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Services
10.1. US Revenue Cycle Management Market, by Type, 2024-2034
10.1.1. Integrated
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Standalone
11.1. US Revenue Cycle Management Market, by Delivery Mode, 2024-2034
11.1.1. Web based
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cloud based
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. US Revenue Cycle Management Market, by End User, 2024-2034
12.1.1. Physician Back office
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Hospitals
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Diagnostic Laboratories
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Other
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Function (2021-2034)
13.1.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.3. Market Revenue and Forecast, by Type (2021-2034)
13.1.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Function (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Type (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Function (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Type (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Function (2021-2034)
13.2.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.3. Market Revenue and Forecast, by Type (2021-2034)
13.2.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Function (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Type (2021-2034)
13.2.7. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Function (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Type (2021-2034)
13.2.10. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Function (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Type (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Function (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Type (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Function (2021-2034)
13.3.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.3. Market Revenue and Forecast, by Type (2021-2034)
13.3.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Function (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Type (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Function (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Type (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Function (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Type (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Function (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Type (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Function (2021-2034)
13.4.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.3. Market Revenue and Forecast, by Type (2021-2034)
13.4.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Function (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Type (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Function (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Type (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Function (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Type (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Function (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Type (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Function (2021-2034)
13.5.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.3. Market Revenue and Forecast, by Type (2021-2034)
13.5.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Function (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Type (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Function (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Type (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Delivery Mode (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. Allscripts Healthcare Solutions
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Change Healthcare Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Cognizant Technology Solutions Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Computer Programs and Systems Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Experian Plc
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Medical Information Technology Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. MEDIREVV
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. OSP Labs
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Quest Diagnostics Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. R1 RCM Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample